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well funded. The one big
difference is the financial
weakness of universities. The lack
of centrally administered
resources makes it much harder
for universities in the UK to foster
new interdisciplinary research
areas, and often forces labs to do
almost everything for themselves,
which can result in considerable
inefficiencies. For biomedical
research in the UK to remain
competitive, the financial health of
the major research universities will
need to be restored, somehow.
Do you enjoy the media work
that you do? Sometimes. I
recently woke up unusually early to
join a television discussion about
how genetics would influence
healthcare. The presenter kicked
off by asking me to clarify the
pronunciation of deoxyribonucleic
acid, and then promptly thanked
me for coming in. But when there
is time to develop an idea, I really
enjoy the challenge of finding a
way to explain and motivate what I
do without the technical jargon.
Like it or not, I do think that
scientists have an obligation to
explain themselves to the public,
who after all fund our work: it is not
only in the public’s interest, but it
can be very helpful to scientists as
well. Certainly for me, explaining
things in popular terms gives me a
much broader perspective on the
work that I do. 
What do you think is the biggest
challenge facing your field? The
big applied challenge in my area of
human genetics is learning how to
incorporate genetic information
into healthcare, both at the level of
genetically personalized
healthcare and in the earlier
stages of personalized lifestyle
choices. In human evolution, the
next major phase will be
identifying the genetic bases of
the traits that have been under
selection in our evolutionary
history. And, closing the circle, I
am convinced many of these traits
will prove to be of medical
relevance, especially in terms of
how people respond to drugs.
Department of Biology, University
College London, Darwin Building,
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What does the term
heterochronic mean?
Heterochronic refers to the
development of cells or tissues at
an abnormal time relative to other
unaffected events in an organism;
the latter can thus serve as
temporal landmarks. Mutations in
heterochronic genes cause certain
cells to adopt cell fates normally
associated with earlier or later
times in development.
Heterochronic genes therefore
regulate the timing and sequence
of developmental events in specific
cell lineages, and thereby
coordinate events throughout a
developing organism.
Why study heterochronic genes
in worms? The nematode
Caenorhabditis elegans provides a
particularly tractable model for
studying heterochronic genes,
owing to its relatively simple and
invariant cell lineages. In the four
larval stages of its post-embryonic
development, C. elegans cells
exhibit stage-specific patterns of
developmental events, such as cell
division and cell fate specification,
with each stage separated by a
molt. Importantly, neither larval
growth nor progression through
the molting cycle in the worm are
affected by known heterochronic
mutations, allowing developmental
events to be monitored relative to
these temporal landmarks.
So, is this just a strange worm
phenomenon? No. Heterochronic
genes have been reported in many
different organisms, including
Drosophila (hunchback, Krüppel,
pdm, castor) and several species
of plants, including Arabidopsis
(HASTY) and rice (mori1).
What do heterochronic genes do
in worms? One class of
heterochronic mutations results in
an early, or precocious, phenotype
in which many of the normal cell
fate decisions of a specific larval
stage are skipped and much of the
worm instead executes the
developmental program of a later
stage. Examples include mutations
in lin-14, lin-28 and lin-41. Worms
with such mutations express adult
cell fates when the animal is still
sexually immature (Figure 1).
Conversely, a second class of
mutations results in a delayed, or
Figure 1.
(A) Cartoon depiction of C. elegans development through the four larval stages (L1 to
L4) to the adult (Ad) in heterochronic mutants relative to wild type. The time axis is from
top to bottom. In lin-14(lf) mutants, the L1-specific developmental program is skipped
and the L2-specific program is executed earlier than in wild-type. In contrast, in lin-29(lf)
mutants, the L4-specific program is repeated and the adult program is not executed.
(B) Working model of genetic interactions in the C. elegans heterochronic gene
pathway. The positions of lin-42, lin-46 and lin-58 in the pathway are not yet known. 
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retarded, phenotype in which many
normal cell fate decisions are
reiterated in subsequent larval
stages. Examples include
mutations in lin-4 and lin-29.
Worms with such mutations do not
express certain adult cell fates,
despite being sexually mature
(Figure 1).
Is there conservation in
heterochronic gene pathways?
An important regulator of the
larval-to-adult transition in worms,
let-7, is conserved across diverse
phyla, having been identified in
flies, sea urchins, humans and
many other organisms. In addition,
it has recently been demonstrated
that the C. elegans heterochronic
gene lin-57 is a worm homolog of
the Drosophila gene hunchback
(hence its new name hbl-1). In the
developing central nervous system
of flies, hunchback regulates the
temporal patterning of cell fate
specification for neuroblasts.
But doesn’t hunchback regulate
spatial patterning in flies?
Hunchback is indeed best known
for its role in anterior–posterior
patterning in the early fly embryo; it
encodes a zinc-finger transcription
factor that acts to establish spatial
domains of gene expression.
Although downstream effectors are
unknown in worms, it is possible
that hbl-1 is able to establish
analogous temporal domains of
gene expression.
What’s the deal with microRNAs
and how are they involved in the
heterochronic gene pathway?
microRNAs are now appreciated
as a new class of small non-coding
RNAs. They are likely to act by
regulating translation of target
mRNAs through binding to
sequences in the 3′ untranslated
regions with partial anti-sense
complementarity. When the
product of the lin-4 heterochronic
gene was found to be a small, non-
coding RNA in 1993, it appeared
that it might be a C. elegans-
specific, molecular oddity. A
second small non-coding RNA, let-
7, was discovered in the
heterochronic gene pathway in
2000, followed by the cloning of
hundreds of small non-coding
RNAs (microRNAs) in 2001 and
beyond, and it is now appreciated
that the heterochronic genes lin-4
and let-7 are the founding
members of a larger microRNA
gene family. 
Are microRNAs involved in other
pathways? Although the first two
microRNAs identified are in the
heterochronic gene pathway, there
is now evidence for roles of
microRNAs in cell proliferation, cell
death, fat metabolism and stress
resistance in flies.
Is there anything we don’t
know? The mechanism of action
of many heterochronic genes
remains to be determined. For
example, lin-14 encodes a novel
nuclear protein with no identified
downstream effectors to date. In
addition, emerging evidence of
phylogenetic conservation of
heterochronic genes leads to the
prospect that mechanisms to
control developmental timing will
be elucidated in other systems.
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Nuclear 
substructure and
dynamics
Angus I. Lamond & Judith E.
Sleeman
The nucleus is the defining feature
of eukaryotic cells. It contains the
chromosomes and is a site of
major metabolic activities, such as
DNA replication, gene
transcription, RNA processing and
ribosome subunit maturation and
assembly. The nucleus is
separated from the surrounding
cytoplasm by a double membrane.
The outer nuclear membrane is
continuous with the endoplasmic
reticulum, or ‘rough ER’, where the
translation of secreted and
membrane bound proteins takes
place. Thus, the nucleus serves to
partition the sites of gene
transcription from those of protein
synthesis in eukaryotic cells.
Movement of proteins and
RNA–protein complexes between
the nucleus and cytoplasm occurs
continually. mRNAs and newly
assembled ribosomal subunits are
exported from their sites of
synthesis in the nucleus to the
cytoplasm. Conversely, as all
proteins are synthesized in the
cytoplasm, nuclear factors, such as
histones, transcriptional regulators
and splicing factors, are selectively
imported into the nucleus. Some
proteins, including hnRNP proteins
and transport receptors, shuttle
repeatedly between the nucleus
and cytoplasm. All of this nucleo-
cytoplasmic exchange occurs via
dedicated multiprotein structures
located in the nuclear envelope,
termed ‘Nuclear Pore Complexes’
(NPCs).
Like the cytoplasm, the nucleus
is compartmentalized (Figure 1).
As well as the chromosomes, the
nucleoplasm contains numerous
classes of ‘nuclear bodies’,
including nucleoli, Cajal bodies
(CBs), gems, splicing speckles and
promyelocytic leukaemia (PML)
bodies. However, in contrast with
cytoplasmic compartments, such
